Vraylar

Chemical Namecariprazine
Dosage FormCapsules (oral; 1.5 mg, 3 mg, 4.5 mg, 6 mg)
Drug ClassAntipsychotics
SystemNervous
CompanyAllergan
Approval Year2015

Indication

  • Treatment of schizophrenia in adults.
  • Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
  • Treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults.
Last updated on 10/8/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Vraylar (cariprazine) Prescribing Information2019Allergan USA, Inc., Madison, NJ